Paraoxonase-1 in chronic liver diseases, neurological diseases and HIV infection

被引:17
作者
Marsillach, J. [1 ]
Parra, S. [1 ]
Ferre, N. [2 ]
Coll, B. [1 ]
Alonso-Villaverde, C. [1 ]
Joven, J. [1 ]
Camps, J. [1 ]
机构
[1] Hosp Univ St Joan, Ctr Recerca Biomed, Inst Recerca Ciencies Salut, Dept Internal Med, C St Joan S-N, Reus 43201, Catalunya, Spain
[2] Hosp Clin Barcelona, Dept Clin Biochem & Mol Genet, Barcelona, Spain
来源
PARAOXNASES: THEIR ROLE IN DISEASE DEVELOPMENT AND XENOBIOTIC METABOLISM | 2008年 / 6卷
关键词
HIV infection; chronic liver diseases; neurological diseases; oxidative stress; paraoxonase-1;
D O I
10.1007/978-1-4020-6561-3_12
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Over recent years there has been a rapid increase in the number of articles reporting paraoxonase-1 (PON1) alterations in diseases other than arteriosclerosis, and which involve an increased degree of oxidative stress. Chronic liver impairment is associated with decreased serum PON1 activity but with increased serum PON1 concentration; this unusual juxtaposition being explained, perhaps, by the molecular alterations related to collagen synthesis and to the inactivation of the enzyme's active site by lipid peroxides. Polymorphisms of the PON1 gene have been shown to be associated with an increased development of several neurological diseases and to influence the organism's capacity to protect against neurotoxins. Many infectious diseases, as HIV infection, produce a high oxidative stress, and alterations in PON1 activity and concentration may be related to the course of the disease.
引用
收藏
页码:187 / +
页数:6
相关论文
共 80 条
[1]
Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease [J].
Akhmedova, SN ;
Yakimovsky, AK ;
Schwartz, EI .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (02) :179-182
[2]
Alonsa-Villaverde C, 2003, AIDS, V17, P1173, DOI [10.1097/00002030-200305230-00009, 10.1097/01.aids.0000060360.78202.05]
[3]
Alonso-Villaverde C, 2005, AIDS, V19, P341
[4]
High-density lipoprotein function - Recent advances [J].
Ansell, BJ ;
Watson, KE ;
Fogelman, AM ;
Navab, M ;
Fonarow, GC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) :1792-1798
[5]
Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities [J].
Aviram, M ;
Hardak, E ;
Vaya, J ;
Mahmood, S ;
Milo, S ;
Hoffman, A ;
Billicke, S ;
Draganov, D ;
Rosenblat, M .
CIRCULATION, 2000, 101 (21) :2510-2517
[6]
Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[7]
Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. [J].
Benmoyal-Segal, L ;
Vander, T ;
Shifman, S ;
Bryk, B ;
Ebstein, R ;
Marcus, EL ;
Stessman, J ;
Darvasi, A ;
Herishanu, Y ;
Friedman, A ;
Soreq, H .
FASEB JOURNAL, 2005, 19 (01) :452-+
[8]
BOWCOCK AM, 1986, AM J HUM GENET, V39, P699
[9]
LINKAGE OF CYSTIC-FIBROSIS TO THE PRO-ALPHA-2(I) COLLAGEN GENE, COL1A2, ON CHROMOSOME-7 [J].
BUCHWALD, M ;
ZSIGA, M ;
MARKIEWICZ, D ;
PLAVSIC, N ;
KENNEDY, D ;
ZENGERLING, S ;
WILLARD, HF ;
TSIPOURAS, P ;
SCHMIEGELOW, K ;
SCHWARTZ, M ;
EIBERG, H ;
MOHR, J ;
BARKER, D ;
DONISKELLER, H ;
TSUI, LC .
CYTOGENETICS AND CELL GENETICS, 1986, 41 (04) :234-239
[10]
SERUM ARYLESTERASE ISOENZYMES IN CHRONIC HEPATITIS [J].
BURLINA, A ;
GALZIGNA, L .
CLINICAL BIOCHEMISTRY, 1974, 7 (03) :202-205